|Toxiciy Grade:||4||City/State/Province:||New York, NY|
|Treatments:||Chemotherapy, Radiation, Immunotherapy, Surgery||Hospital:||Columbia University New York|
This phase 2 study involved 27 malignant peritoneal mesothelioma patients with an average age of 53 years (range of 31-75); 20 were male.
Patients were treated with surgery; chemotherapy with cisplatin, doxorubicin, and mitomycin; immunotherapy with interferon gamma; and radiation therapy.
The most severe toxicities were of grade 4 and included grade 3-4 hearing disorders and bowel obstruction.
The median overall survival was 70 months.
Correspondence: Dr. Mary Hesdorffer; email: firstname.lastname@example.org